These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33655582)

  • 1. Precursor-targeted immune-mediated anemia in a dog with a stage IV mast cell tumor and bone marrow infiltration.
    Akiyoshi M; Hisasue M; Neo S; Akiyoshi M
    Vet Clin Pathol; 2021 Mar; 50(1):151-157. PubMed ID: 33655582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission of two canine cases with precursor-targeted immune-mediated anemia after combination therapy with prednisolone, cyclosporine, and oclacitinib.
    Yuki M; Taira H; Narita M; Inden T; Yokota S; Naito E; Maeda S
    Open Vet J; 2023 Sep; 13(9):1205-1211. PubMed ID: 37842117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and cytologic bone marrow findings in dogs with suspected precursor-targeted immune-mediated anemia and associated phagocytosis of erythroid precursors.
    Lucidi CA; de Rezende CLE; Jutkowitz LA; Scott MA
    Vet Clin Pathol; 2017 Sep; 46(3):401-415. PubMed ID: 28582594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presumptive precursor-targeted immune-mediated anemia concurrent with gastrointestinal lymphoma in a cat.
    Akiyoshi M; Hisasue M; Neo S; Akiyoshi M
    J Vet Med Sci; 2020 Nov; 82(11):1570-1576. PubMed ID: 32863286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of precursor-targeted immune-mediated anemia in dogs: 66 cases (2004-2013).
    Assenmacher TD; Jutkowitz LA; Koenigshof AM; de A Lucidi C; Scott MA
    J Am Vet Med Assoc; 2019 Aug; 255(3):366-376. PubMed ID: 31298643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs: 43 cases (1988-1999).
    Stokol T; Blue JT; French TW
    J Am Vet Med Assoc; 2000 May; 216(9):1429-36. PubMed ID: 10800515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement.
    Marconato L; Bettini G; Giacoboni C; Romanelli G; Cesari A; Zatelli A; Zini E
    J Vet Intern Med; 2008; 22(4):1001-7. PubMed ID: 18564225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated hemolytic anemia and pure red cell aplasia in a Jack Russell Terrier during treatment for hypoadrenocorticism.
    Yokota S; Yuki M
    Vet Clin Pathol; 2024 Mar; 53(1):69-73. PubMed ID: 38433116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone and danazol for treatment of immune-mediated anemia, thrombocytopenia, and ineffective erythroid regeneration in a dog.
    Holloway SA; Meyer DJ; Mannella C
    J Am Vet Med Assoc; 1990 Oct; 197(8):1045-8. PubMed ID: 2243038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997).
    McManus PM
    J Am Vet Med Assoc; 1999 Aug; 215(3):355-7. PubMed ID: 10434973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G and phosphatidylserine in regenerative and nonregenerative immune-mediated anemias of dogs.
    Lucidi CA; Gerlach JA; Jutkowitz A; Scott MA
    J Vet Intern Med; 2021 Nov; 35(6):2713-2721. PubMed ID: 34716708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hyperferremia and hyperferritinemia in a dog with precursor-directed immune-mediated anemia.
    Zersen KM; Gregory CW; Jeffries CM; Olver C
    Vet Clin Pathol; 2022 Dec; 51(4):491-494. PubMed ID: 35578377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breed predispositions, clinical findings, and prognostic factors for death in dogs with nonregenerative immune-mediated anemia.
    Woolhead VL; Szladovits B; Chan A; Swann JW; Glanemann B
    J Vet Intern Med; 2021 Jan; 35(1):252-260. PubMed ID: 33617109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow, blood, and clinical findings in dogs treated with phenobarbital.
    Scott TN; Bailin HG; Jutkowitz LA; Scott MA; Lucidi CA
    Vet Clin Pathol; 2021 Mar; 50(1):122-131. PubMed ID: 33751634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatosplenic lymphoma and visceral mast cell tumor in the liver of a dog with synchronous and multiple primary tumors.
    Akiyoshi M; Hisasue M; Asakawa MG; Neo S; Akiyoshi M
    Vet Clin Pathol; 2022 Sep; 51(3):414-421. PubMed ID: 35909229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabot rings as a result of severe dyserythropoiesis in a dog.
    Lukaszewska J; Lewandowski K
    Vet Clin Pathol; 2008 Jun; 37(2):180-3. PubMed ID: 18533917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonregenerative immune-mediated anemia associated with a diffuse large B-cell lymphoma in a captive jaguar (Panthera onca).
    Keresztes MA; Henrich M; Baloi P; Gerst S; Rudnick JC; Langenstein J; Moritz A; Bauer N
    Vet Clin Pathol; 2017 Dec; 46(4):597-604. PubMed ID: 28902958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of canine mast cell tumors with CCNU (lomustine).
    Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM
    J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorrhagic diathesis and bone marrow aplasia secondary to lomustine overdose in a dog.
    Henker LC; Kemper RT; Bianchi SP; Bandinelli MB; Pavarini SP
    Vet Clin Pathol; 2019 Jun; 48(2):255-258. PubMed ID: 31062418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.